The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Plasma Periostin Levels and Degree of Change (e.g., Slope) - Primary Physiologic Efficacy Endpoint
Timeframe: 24 hours, 48 hours, and 72-hours following enrollment
Drug-related adverse event rate (Primary Safety Endpoint)
Timeframe: During hospitalization, approximately 3 days